Regrettably, 0.5m$ implied revenue from Brands in Q4 (down from 1.4m$ in Q3) looks shockingly low to me; whatever the reason is, this has important ramifications on COGS, GM, Cash Flow and expected future growth.
At this stage, it no longer seems likely to me that KTD was either CF or EBITDA positive for 2H2021; as such, I had to consider my original performance milestones as being breached and took my loss accordingly.
Good luck to all holders
- Forums
- ASX - By Stock
- HLF
- Ann: FY21 Revenue Announcement
Ann: FY21 Revenue Announcement, page-38
-
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLF (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online